O

Obudai Egeszsegugyi Centrum | Rheumatology Department

Research site

(Unclaimed)

Location

Lajos utca 74-76, Budapest, Budapest, Hungary

Site insights

Top conditions

Top treatments

Olezarsen

Olokizumab

Risankizumab

Orismilast

Adalimumab

Vedolizumab

Linagliptin

Methotrexate

Upadacitinib

ABT-494

Parent organization

This site is a part of Obudai Egeszsegugyi Centrum

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 (U-ENDURE)

A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered...

Active, not recruiting

Crohn's Disease

Drug: Placebo for Upadacitinib

Drug: Upadacitinib

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP)

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large...

Enrolling

Ulcerative Colitis

Drug: Risankizumab

Drug: Vedolizumab